An Experimental Vaccine for Chlamydia Shows Promise in Early Study
A Phase 1 trail for a possible new chlamydia vaccine had encouraging results. Chlamydia is one of the most common STIs worldwide—a vaccine could dramatically change this landscape.
Doxy-PEP is a New Strategy to Help Prevent STIs
Doxy-PEP is the strategy of taking the antibiotic doxycycline after condomless oral or anal sex to prevent chlamydia, gonorrhea, or syphilis.
New Studies Add to Evidence that Doxy-PEP Works for STI Prevention
New studies add to our evidence that Doxy-PEP is working to prevent bacterial STIs among transgender women and men who have sex with men.
PID is a leading cause of infertility in women
Pelvic Inflammatory Disease (PID) Pelvic inflammatory disease (PID) is a serious infection in the upper genital tract/reproductive organs (uterus, fallopian tubes and ovaries) of women. PID can be sexually transmitted or naturally occurring. It can lead to infertility in women (unable to have children) or life-threatening complications. Women between ages 15 and 25 have the […]
The State of STIs — CDC Reports an Alarming Rise in Syphilis
CDC released new surveillance data on sexually transmitted infections. There were 2.5 million cases of chlamydia, gonorrhea, and syphilis reported in the United States in 2022. Rates of gonorrhea and chlamydia remain high, and rates of syphilis have gone up an alarming 80% since 2018.
Improving Chlamydia Screening Rates Through Opt-Out Screening
Jointly provided by Postgraduate Institute for Medicine and American Sexual Health Association. This activity is supported by an independent educational grant from Hologic.
Chlamydia: A Common and Curable Infection
Chlamydia: A Common and Curable Infection Chlamydia is a common and curable infection caused by the bacteria chlamydia trachomatis. It is the most common reportable STI in the U.S. In 2022, there were about 1.6 million cases reported. Chlamydia can cured with antibiotic treatment, but if left untreated it can lead to complications such as […]